Four studies identify alternative origins for cells of the developing lymphatic system, challenging the long-standing view that they all come from veins.
Researchers develop a CRISPR-based, two-phage system that sensitizes resistant bacteria to antibiotics and selectively kills any remaining drug-resistant bugs.